Drawing for REVIMMUNE

USPTO serial 88198822

REVIMMUNE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BLACK, MILDRED ELIZABETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REVIMMUNE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Keith W. Medansky

Keith W. Medansky DLA PIPER LLP (US)P.O. BOX 64807CHICAGO, IL 60664-0807UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Biological and pharmaceutical preparations, namely, biological and pharmaceutical preparations and substances for the prevention and treatment of blood disease and cancer, viral and other infectious diseases, and the modulation and treatment of immune system related diseases and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 11, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 11, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 9, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 9, 2021NOACCORRECTED NOA E-MAILED—
Dec 8, 2021EX5GSOU EXTENSION 5 GRANTED—
Dec 8, 2021DPCCDIVISIONAL PROCESSING COMPLETE—
Dec 8, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 29, 2021DRRRDIVISIONAL REQUEST RECEIVED—
Nov 29, 2021ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Nov 24, 2021EXT5SOU EXTENSION 5 FILED—
Nov 24, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 27, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 25, 2021EX4GSOU EXTENSION 4 GRANTED—
May 25, 2021EXT4SOU EXTENSION 4 FILED—
May 25, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 26, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 24, 2020EX3GSOU EXTENSION 3 GRANTED—
Nov 24, 2020EXT3SOU EXTENSION 3 FILED—
Nov 24, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 2, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 29, 2020EX2GSOU EXTENSION 2 GRANTED—
May 29, 2020EXT2SOU EXTENSION 2 FILED—
May 29, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 20, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 18, 2019EX1GSOU EXTENSION 1 GRANTED—
Nov 18, 2019EXT1SOU EXTENSION 1 FILED—
Nov 18, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 4, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 9, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 9, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 20, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 26, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 22, 2019DOCKASSIGNED TO EXAMINER—
Dec 6, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 22, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance